Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Maynard

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Opinion in Biotechnology|August 17, 2023
Editorial overview: Tissue, cell, and pathway engineering: Recent innovations in biomedical technologiesJennifer A Maynard, Laura Segatori
Biochemistry|November 11, 2009
Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7Jamie N Sutherland, Jennifer A Maynard
Current Opinion in Chemical Engineering|June 19, 2018
Engineering therapeutic antibodies to combat infectious diseasesEllen K Wagner, Jennifer A Maynard
Current Opinion in Chemical Biology|May 15, 2007
Microarrays in infection and immunityJennifer A Maynard, Ryan Myhre, Benjamin Roy
Biochemistry|March 26, 2016
Inclusion of an RGD Motif Alters Invasin Integrin-Binding Affinity and SpecificityTarik A Khan, Xianzhe Wang, Jennifer A Maynard
Proteins|August 3, 2007
Modeling the structure of mAb 14B7 bound to the anthrax protective antigenArvind Sivasubramanian, Jennifer A Maynard, Jeffrey J Gray
Current Opinion in Biotechnology|October 1, 2022
Engineering antibodies for conditional activity in the solid tumor microenvironmentYutong Liu, Annalee W Nguyen, Jennifer A Maynard
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2019
Engineering Antibodies on the Surface of CHO CellsAnnalee W Nguyen, Kevin Le, Jennifer A Maynard
Analytical Biochemistry|December 14, 2011
Restriction enzyme-free construction of random gene mutagenesis libraries in Escherichia coliJen C Pai, Kevin C Entzminger, Jennifer A Maynard
Current Opinion in Chemical Engineering|January 21, 2014
Back to the future: recombinant polyclonal antibody therapeuticsXian-Zhe Wang, Vincent W Coljee, Jennifer A Maynard
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Opinion in Biotechnology|August 17, 2023
Editorial overview: Tissue, cell, and pathway engineering: Recent innovations in biomedical technologiesJennifer A Maynard, Laura Segatori
Biochemistry|November 11, 2009
Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7Jamie N Sutherland, Jennifer A Maynard
Current Opinion in Chemical Engineering|June 19, 2018
Engineering therapeutic antibodies to combat infectious diseasesEllen K Wagner, Jennifer A Maynard
Current Opinion in Chemical Biology|May 15, 2007
Microarrays in infection and immunityJennifer A Maynard, Ryan Myhre, Benjamin Roy
Biochemistry|March 26, 2016
Inclusion of an RGD Motif Alters Invasin Integrin-Binding Affinity and SpecificityTarik A Khan, Xianzhe Wang, Jennifer A Maynard
Proteins|August 3, 2007
Modeling the structure of mAb 14B7 bound to the anthrax protective antigenArvind Sivasubramanian, Jennifer A Maynard, Jeffrey J Gray
Current Opinion in Biotechnology|October 1, 2022
Engineering antibodies for conditional activity in the solid tumor microenvironmentYutong Liu, Annalee W Nguyen, Jennifer A Maynard
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2019
Engineering Antibodies on the Surface of CHO CellsAnnalee W Nguyen, Kevin Le, Jennifer A Maynard
Analytical Biochemistry|December 14, 2011
Restriction enzyme-free construction of random gene mutagenesis libraries in Escherichia coliJen C Pai, Kevin C Entzminger, Jennifer A Maynard
Current Opinion in Chemical Engineering|January 21, 2014
Back to the future: recombinant polyclonal antibody therapeuticsXian-Zhe Wang, Vincent W Coljee, Jennifer A Maynard
Pageof 8